Real-world Factors Predicting Complete Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer

被引：0
|
作者：
Rubasingham, J. [1 ]
Loo, V. [1 ]
机构：
[1] Colchester Gen Hosp, Colchester, Essex, England
来源：
CLINICAL ONCOLOGY | 2019年 / 31卷 / 07期
关键词：
D O I：
10.1016/j.clon.2019.03.033
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E113 / E114
页数：2
相关论文
共 50 条
  • [31] Utility of synthetic MRI in predicting pathological complete response of various breast cancer subtypes prior to neoadjuvant chemotherapy
    Matsuda, M.
    Fukuyama, N.
    Matsuda, T.
    Kikuchi, S.
    Shiraishi, Y.
    Takimoto, Y.
    Kamei, Y.
    Kurata, M.
    Kitazawa, R.
    Kido, T.
    [J]. CLINICAL RADIOLOGY, 2022, 77 (11) : 855 - 863
  • [32] Real world evidence of neoadjuvant chemotherapy for breast cancer treatment in a Brazilian multicenter cohort: correlation of pathological complete response and overall survival
    Antonini, Marcelo
    Mattar, Andre
    Richter, Fernanda Grace Bauk
    Pannain, Gabriel
    Amorim, Andressa
    Diogenes, Marina
    Ferraro, Odair
    Gebrim, Luiz
    Lopes, Reginaldo Coelho
    Real, Juliana
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [33] Integrating Histological Images and Clinical Information for Predicting the Pathological Complete Response for Breast Cancer Receiving Neoadjuvant Chemotherapy
    Li, Fengling
    Yang, Yongquan
    Zhao, Yuanyuan
    Fu, Jing
    Xiao, Xiuli
    Bu, Hong
    [J]. LABORATORY INVESTIGATION, 2023, 103 (03) : S165 - S166
  • [34] Clinicopathologic factors predicting complete pathological response to neoadjuvant chemoradiotherapy in esophageal cancer
    MacGuill, M.
    Mulligan, E.
    Ravi, N.
    Rowley, S.
    Byrne, P. J.
    Hollywood, D.
    Kennedy, J.
    Keeling, P. N.
    Reynolds, J. V.
    [J]. DISEASES OF THE ESOPHAGUS, 2006, 19 (04) : 273 - 276
  • [35] Predicting Factors for Complete Pathological Response After Neoadjuvant Therapy for Esophageal Cancer
    Morgenstern, S.
    Menasherov, N.
    Bard, V.
    Kundel, Y.
    Domachevsky, L.
    Bernstine, H.
    Brenner, B.
    Kashtan, H.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S33 - S33
  • [36] Pathological complete response after neoadjuvant chemotherapy plus pertuzumab and trastuzumab for HER2+early breast cancer: Real-world data from NeoPowER study
    Canino, F.
    Barbolini, M.
    De Giorgi, U. F. F.
    Gianni, L.
    Maestri, A.
    Moscetti, L.
    Omarini, C.
    Zamagni, C.
    Costantini, R. Cuoghi
    Tamburrano, F.
    Antonelli, G.
    Baglio, F.
    Belluzzi, L.
    Martinelli, G.
    Natalizio, S.
    Ponzoni, O.
    Dominici, M.
    Piacentini, F.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S289 - S290
  • [37] Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtype
    Fukuda, Takayo
    Horii, Rie
    Gomi, Naoya
    Miyagi, Yumi
    Takahashi, Shunji
    Ito, Yoshinori
    Akiyama, Futoshi
    Ohno, Shinji
    Iwase, Takuji
    [J]. SPRINGERPLUS, 2016, 5 : 1 - 9
  • [38] Nomogram for predicting pathological complete response to neoadjuvant chemotherapy in patients with advanced gastric cancer
    Chen, Yong-He
    Xiao, Jian
    Chen, Xi-Jie
    Wang, Hua-She
    Liu, Dan
    Xiang, Jun
    Peng, Jun-Sheng
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (19) : 2427 - 2439
  • [39] Nomogram for predicting pathological complete response to neoadjuvant chemotherapy in patients with advanced gastric cancer
    Yong-He Chen
    Jian Xiao
    Xi-Jie Chen
    Hua-She Wang
    Dan Liu
    Jun Xiang
    Jun-Sheng Peng
    [J]. World Journal of Gastroenterology, 2020, (19) : 2427 - 2439
  • [40] Real-World Data on Pathological Response and Survival Outcomes After Neoadjuvant Chemotherapy in HER2-Low Breast Cancer Patients
    Guan, Dandan
    Shi, Qingyang
    Zheng, Yajuan
    Zheng, Chaopeng
    Meng, Xuli
    [J]. CLINICAL BREAST CANCER, 2024, 24 (05) : 463 - 472.e2
12345